相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Interleukin-6 Receptor Directly Blocks Osteoclast Formation In Vitro and In Vivo
Roland Axmann et al.
ARTHRITIS AND RHEUMATISM (2009)
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
Norihiro Nishimoto et al.
MODERN RHEUMATOLOGY (2009)
IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system
Misato Hashizume et al.
RHEUMATOLOGY INTERNATIONAL (2009)
Cartilage homeostasis in health and rheumatic diseases
Mary B. Goldring et al.
ARTHRITIS RESEARCH & THERAPY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17
M. Hashizume et al.
RHEUMATOLOGY (2008)
ADAMTS-5: The story so far
Amanda J. Fosang et al.
EUROPEAN CELLS & MATERIALS (2008)
Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage
Satoko Naito et al.
PATHOLOGY INTERNATIONAL (2007)
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): Evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
Norihiro Nishimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: Comparative analyses with ADAMTS-5,-9,-16 and-18
WL Zeng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Oncostatin M in combination with tumour necrosis factor α induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or-2
W Hui et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis
SS Glasson et al.
NATURE (2005)
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
H Stanton et al.
NATURE (2005)
Functional evolution of ADAMTS genes: Evidence from analyses of phylogeny and gene organization
AC Nicholson et al.
BMC EVOLUTIONARY BIOLOGY (2005)
Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice
SS Glasson et al.
ARTHRITIS AND RHEUMATISM (2004)
ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage
LA Collins-Racie et al.
MATRIX BIOLOGY (2004)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro
B Bau et al.
ARTHRITIS AND RHEUMATISM (2002)
Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage
AM Malfait et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression and regulation of aggrecanase in arthritis:: The role of TGF-β
Y Yamanishi et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression and activity of ADAMTS-5 in synovium
MN Vankemmelbeke et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
SA Jones et al.
FASEB JOURNAL (2001)
ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan
K Kuno et al.
FEBS LETTERS (2000)
Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines of the IL-6 family
R Sobota et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Fibroblast biology - Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis
T Pap et al.
ARTHRITIS RESEARCH (2000)
分享论文
